 |
Previous Article | Next Article 
The Journal of Neuroscience, January 15, 2003, 23(2):693-699
Effects of Sex and Estrogen on Behavioral Sensitization to
Cocaine in Rats
Ming
Hu and
Jill B.
Becker
Psychology Department, Neuroscience Program and Reproductive
Sciences Program, University of Michigan, Ann Arbor, Michigan 48109
 |
ABSTRACT |
Estrogen rapidly enhances dopamine (DA) activity in the striatum
and nucleus accumbens as well as behavioral responses to psychomotor
stimulants in female rats but not males. This experiment was conducted
to investigate the role of pulsatile estrogen treatment on and sex
differences in the development and expression of sensitization of
cocaine-induced rotational behavior in rats with unilateral striatal DA
denervation. Four groups were tested: ovariectomized (OVX) females
treated with 5 µg of estradiol benzoate (OVX+E), OVX females,
castrated (CAST) males, and intact males. Animals received
estrogen or vehicle 30 min before cocaine (0, 5, 10, or 20 mg/kg, i.p.)
on 4 consecutive days, followed by 3 d without treatment for 3 weeks. At the conclusion of the experiment, animals were withdrawn from
hormone and/or cocaine for 10 d, and all groups underwent a
challenge test with 10 mg/kg cocaine. We report here that OVX+E females
exhibit significantly greater sensitization of rotational behavior with
a faster rate of sensitization than the three other groups. There is
also a sex difference independent of gonadal hormones: OVX females
exhibit a greater magnitude of sensitization of rotational behavior
than do CAST males at 20 mg/kg cocaine. Furthermore, on the challenge
test, OVX+E animals tested without estrogen treatment continue to
exhibit greater rotational behavior than do all other groups. Thus,
estrogen enhances sensitization to cocaine, there are sex differences
in behavioral sensitization, and sensitization that develops under
conditions with estrogen persists even when estrogen levels are low.
Key words:
cocaine; behavioral sensitization; rotational
behavior; estrogen; sex differences; drug abuse
 |
Introduction |
Cocaine abuse by women has increased
in the last decade, such that of the 1.8 million Americans who use
cocaine, ~30% are now female, making this a growing public health
concern (Wetherington and Roman, 1995 ). Sex differences in the pattern
of cocaine abuse and behavioral responses to cocaine indicate that the
pattern of cocaine use and onset of addiction to cocaine is more rapid in women than in men (Lynch and Carroll, 1999 ). Women begin using cocaine and enter treatment at earlier ages than men (Griffin et al.,
1989 ; Mendelson et al., 1991 ) and have more severe cocaine use at
intake than men (Kosten et al., 1993 ). Furthermore, cocaine cues induce
more drug craving in female than male addicts (Robbins et al., 1999 ).
Collectively, these results suggest that women may be more sensitive to
the addictive properties of cocaine than men.
Repeated exposure to psychomotor stimulants, such as cocaine, results
in enhanced behavioral responses to subsequent drug treatment in humans
and laboratory animals (Robinson and Becker, 1986 ; Strakowski et al.,
1996 ). This effect of repeated drug treatments is known as behavioral
sensitization. Sensitization-related neuroadaptations may play an
important role in the processes of addiction and craving (Lett, 1989 ;
Piazza et al., 1990 ; Robinson and Berridge, 1993 ; Berridge and
Robinson, 1995 ; Wyvell and Berridge, 2001 ). In the laboratory, sex
differences are found in behavioral sensitization induced by cocaine or
amphetamine (AMPH), in which female rats have been reported to exhibit
greater sensitization than do intact male rats (Robinson et al., 1982 ;
Glick and Hinds, 1984 ; Robinson, 1984 ; Camp and Robinson, 1988a ,b ; van
Haaren and Meyer, 1991 ; Forgie and Stewart, 1994 ) and to sensitize at a
lower dose of cocaine than male rats (Post et al., 1981 ).
Research on rodents suggests that ovarian hormones may play a role in
sex differences in the response to acute treatment with psychomotor
stimulants (Becker and Ramirez, 1981 ; Becker, 1990a , 1999 , 2000 ).
During naturally occurring behavioral estrus, AMPH- or cocaine-induced
behaviors are greater than on other days of the estrous cycle (Becker
et al., 1989 ; Sell et al., 2000 ). Ovariectomy attenuates, whereas
estrogen treatment in ovariectomized female rats rapidly enhances,
behaviors thought to be mediated by the striatal dopamine (DA) system
(Becker, 1990a ,b ; Castner et al., 1993 ; Sell et al., 2000 ).
The role of ovarian hormones in development or expression of behavioral
sensitization to psychomotor stimulants has been less well studied. In
general, in rats, intact females or gonadal hormone-treated females
exhibit greater sensitization of cocaine-induced locomotor activity or
stereotyped behaviors than do ovariectomized females, although the
results vary with dose of cocaine, dose of estrogen, and strain of rat
(Peris et al., 1991 ; van Haaren and Meyer, 1991 ; Sircar and Kim, 1999 ;
Sell et al., 2002 ). The present study was designed to further elucidate
the role of the gonadal steroid hormone estrogen on and sex differences
in cocaine-induced sensitization of rotational behavior.
 |
Materials and Methods |
Animals. Male and female Sprague Dawley rats (Harlan
Sprague Dawley, Indianapolis, IN), weighing 200-225 gm at the
start of the experiment, were housed two to three per cage under a
14/10 hr light/dark cycle. Animals were housed in a room maintained at
a constant temperature of 20-21°C, with phytoestrogen-free rodent
chow (2014 Teklad Global 14% protein rodent maintenance diet, Harlan
rat chow; Harlan Teklab, Madison, WI) and water available ad
libitum. All procedures were performed according to a protocol approved by the University of Michigan Committee for Use and Care of Animals.
Surgery. Approximately 1 week after arrival, animals
received 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal DA
pathway according to the following protocol. Animals received 0.1 ml of atropine methyl nitrate (0.5 mg/ml, i.p.) to reduce salivation. Ten
minutes later, animals were given pargyline (35 mg/kg, i.p.) to inhibit
monoamine oxidase metabolism of 6-OHDA and desipramine (15 mg/kg, i.p)
to protect noradrenergic cells and were anesthetized with sodium
pentobarbital (for females, 20 mg/kg, i.p.; for males, 25 mg/kg, i.p.)
supplemented with isoflurane. Lesion coordinates (based on a 200-250
gm rat) measured from bregma, skull flat, were as follows: posterior,
5.0 mm; lateral, 2.0 mm; and ventral, 7.7 mm. A solution of 8.26 µg
of 6-OHDA hydrobromide (2 µg/µl in 0.1 mg/ml
L-ascorbic acid in 0.9% sterile saline) was
infused into the substantia nigra through a 29 gauge cannula at a rate of 0.5 µl/min for 8.25 min (for a total infusion of ~4.13 µl). The infusion cannula was left in place for 2 min before being slowly
raised to allow the infusion to disperse.
Two weeks later, all rats underwent gonadectomy or sham surgery under
isoflurane anesthesia. For females, ovariectomy is conducted using a
dorsal approach. The skin is opened with an incision ~1 cm long along
the midline just below the ribs, and a small incision (~0.5 cm) is
made through the muscle ~1.5-2 cm lateral to the midline. The ovary
is externalized with blunt forceps, and the tissue between the ovary
and uterus is clamped with a hemostat. The ovary is removed, and the
hemostat remains in place until there is no bleeding when it is
released. The uterus with associated tissue is returned to the abdomen.
The procedure is repeated on the other side, and wound closure is via
11 mm wound clips. During castration, the testes are removed via a
ventral approach. For this procedure, the scrotal sac is opened, and
the testis is visualized. The blood supply to the testis is closed with
suture material, and the testis is removed. The wound is ~0.5 cm and
is closed with 11 mm wound clips. After 4 d of recovery, all
female rats underwent vaginal lavage testing daily for 10 consecutive
days to confirm cessation of cycling. Male rats were assigned randomly to receive either castration or sham castration surgery. On days in
which female rats received vaginal lavage, male rats were handled.
Rotational behavior. Subjects were assigned to one of four
groups: (1) ovariectomized (OVX) females treated with 5 µg of
estradiol benzoate in 0.1 ml of peanut oil (EB) (OVX+E); (2) OVX
females treated with 0.1 ml of peanut oil vehicle; (3) castrated males treated with vehicle (CAST); and (4) sham-castrated males (SHAM) treated with vehicle. Each rat was injected subcutaneously with either
EB or vehicle and then placed into the rotometer (Becker et al., 1982 ;
McFarlane et al., 1992 ). After a 30 min habituation period, each rat
was injected intraperitoneally with either saline or 5, 10, or 20 mg/kg
cocaine and then tested for 1 hr. Numbers of animals in each group at
each dose are included in the figure legends. The computer program
recorded 360° rotations in 5 min intervals for 60 min during the
rotation test period. Rats were tested for 4 consecutive days and then
had 3 d off each week for 3 consecutive weeks. On each test day,
animals received EB or oil, and, on the 3 d off, no hormone or
cocaine was administered.
This dose of EB and treatment regimen was chosen because it is known to
produce concentrations of serum estrogen that are in the physiological
range for the rat (Butcher et al., 1974 ; Henderson et al. 1977a ,b ). At
this dose of EB per body weight, serum concentrations of estradiol peak
within 1 hr and return to baseline by 24 hr (Cheng and Johnson, 1974 ).
To demonstrate that this dose of EB is sufficient to induce a
physiological response, prolactin and luteinizing hormone levels
are lowered after daily treatment with 5 µg of EB in the OVX rat but
not with lower doses of EB even after 7 d of treatment (Mallampati
and Johnson, 1973 ). We believe that this treatment regimen allows us to
examine the acute response to estrogen treatment on each day of
testing, but it is possible that there is some carryover. Thus, we
chose to characterize this exposure to estrogen as "pulsatile"
estradiol stimulation, because we know that, on each day, there will be a peak of estradiol during the time animals are tested behaviorally.
Challenge day. Ten days after the final testing day, all
rats were tested in the rotometers as described above, with the
exception that all rats were treated with 0.1 ml of vehicle 30 min
before the test, and all animals received 10 mg/kg cocaine as the
challenge dose.
Striatal DA determination. After the challenge dose, all
rats were decapitated; their brains were removed rapidly, and the striatum on each side was dissected. The two striatal samples were each
weighed and then homogenized in 400 µl of a solution containing an
internal standard (dihydroxybenzylamine), 2 mM
EDTA, and 0.1 M sodium metabisulfate dissolved in
0.05N perchloric acid. These samples were then centrifuged at 5000 × g, filtered through 0.2 µm filters, and transferred to
autosampler vials for DA analysis using HPLC with
electrochemical detection (Coulochem II; ESA, Waltham, MA), as
described previously (Becker and Freed, 1988 ). Percentage DA depletions
were calculated by subtracting the concentration of DA per
milligram of wet tissue weight on the lesioned side from the
value on the intact side. This result is divided by the value on the
intact side, providing a percentage depletion of DA. Rats whose
percentage depletion was <95% and rats who turned in the wrong
direction or who did not show a clear bias during testing were
eliminated from the study.
Statistical analysis. The total number of net rotations was
calculated as the sum of the number of contraversive rotations during
the 60 min testing period minus the number of ipsiversive rotations for
each rat. To determine the rate of sensitization, the data for all
12 d of testing were used for animals treated with 20 mg/kg
cocaine, and the data for the first 8 d of testing were used for
animals treated with 5 or 10 mg/kg cocaine. A linear regression was
calculated for each animal using the days indicated above [when the
increase in turning was most linear as determined by the correlation
coefficient (r2)]. The mean
value of the slope for each group was calculated to predict the rate of sensitization.
All data were analyzed using the computer program Statview 4.5 (Systat,
Evanston, IL) for Macintosh (Apple Computers, Cupertino, CA).
Comparisons were made by ANOVA and subsequent post hoc
comparisons with Fisher's PLSD test, with significance set at
p 0.05 for individual comparisons.
 |
Results |
All rats that were repeatedly treated with cocaine exhibited
sensitization of rotational behavior, as defined by a progressive enhancement of behavior with repeated drug administration. On a two-way
ANOVA test, there was a significant interaction between group and dose
of cocaine (F(9,1538) = 27.06, p < 0.0001; group effect,
F(3,3) = 104.89, p < 0.0001; cocaine dose, F(3,9) = 432.02, p < 0.0001). When rotational data from session 12 were
compared with rotational data from session 1, with doses of 5, 10, and 20 mg/kg cocaine, all four groups showed a significant increase in
behavior over the course of the experiment (p < 0.0001).
Acute response to cocaine
Acute effects of the first treatment with 5, 10, and 20 mg/kg
cocaine or saline on rotational behavior are shown in Figure 1. Although there were slightly more
rotations in the OVX+E and OVX female groups than in the CAST and SHAM
male groups at the 5 and 10 mg/kg doses of cocaine, there was no
significant effect of group (F(3,3) = 0.937; p = 0.4256) on the first day of testing. There
was a significant effect of dose
(F(3,9) = 9.922; p < 0.0001) on the first day of rotational behavior testing, so that all
groups exhibited more rotational behavior with higher doses of cocaine than with lower doses (Fig. 1).

View larger version (26K):
[in this window]
[in a new window]
|
Figure 1.
Net rotations per hour induced by saline or
cocaine (5, 10, or 20 mg/kg) during the first test session. There were
no group differences at any dose. Each bar represents the mean ± SEM. Gray bars represent the data from SHAM (intact)
male rats, stippled bars the data from CAST male rats,
open bars the data from OVX female rats, and
solid bars the data from OVX+E female rats.
|
|
Cocaine at 20 mg/kg
As shown in Figure 2, there were sex
differences and effects of estrogen on sensitization of rotational
behavior induced by repeated treatment with 20 mg/kg cocaine. First,
all of the groups showed sensitization of rotational behavior, but the
OVX+E group exhibited a greater rate of sensitization than did the
other groups (F(3, 27) = 7.312;
p < 0.001). On post hoc comparisons, the
rate of sensitization of the OVX+E group was greater than for the OVX group (p < 0.0378), the CAST group
(p < 0.0021), and the SHAM group
(p < 0.001). There was no significant
difference between OVX and CAST groups and no significant difference
between the two male groups in the rate of sensitization.

View larger version (27K):
[in this window]
[in a new window]
|
Figure 2.
Effect of estrogen on and sex differences in
rotational behavioral induced by repeated treatment with 20 mg/kg
cocaine. Left, Mean ± SEM number of net rotations
per hour during each of the 12 test sessions. The OVX+E group
(n = 8; solid triangles) was treated
with 5 µg of EB 30 min before 20 mg/kg cocaine. Open
circles represent the data from OVX females
(n = 8), open diamonds the data from
CAST male rats (n = 8), and solid
squares the data from SHAM male rats (n = 7). Right, Mean ± SEM rate of sensitization from
linear regression calculated for each rat from the data for the 12 testing sessions. *Net rotations per hour for OVX animals were
significantly greater than SHAM (p < 0.0003) and CAST (p < 0.0001) groups; **net
rotations per hour for OVX+E animals were significantly greater than
OVX (p < 0.0001), CAST
(p < 0.0001), and SHAM
(p < 0.0001) groups; ***rates of
sensitization for OVX+E animals were significantly greater than OVX
(p < 0.038), CAST
(p < 0.002), and SHAM
(p < 0.001) groups.
|
|
When net rotations per hour were compared across testing days for
animals receiving 20 mg/kg cocaine, there was a significant interaction
between group and test session (group × session,
F(33,297) = 3.765, p < 0.0001; main effect of group,
F(3,27) = 15.124, p < 0.0001; session, F(11,33) = 39.416, p < 0.0001). In post hoc comparisons, the
OVX+E group exhibited more net rotations than did all other groups when
the entire 12 sessions of behavior were compared
(p < 0.0001). Furthermore, the OVX group
receiving 20 mg/kg cocaine exhibited more net rotations than did either
male group (p < 0.003). There was no
significant difference between the CAST and SHAM groups.
Cocaine at 10 mg/kg
With 10 mg/kg cocaine, all of the groups again showed
sensitization of rotational behavior (Fig.
3), but the OVX+E group exhibited a
greater rate of sensitization and more net rotations than did all other
groups. On a one-way ANOVA test of the slopes of all groups, there was
a main effect of group (F(3,28) = 0.043; p < 0.001), indicating group differences in the
rate of sensitization. Post hoc comparisons indicated that
the OVX+E group sensitized more rapidly than did the OVX group
(p < 0.0383), the CAST group (p < 0.0215), and the SHAM group
(p < 0.0141). There was no significant difference between the OVX and CAST groups and no significant difference between the two male groups.

View larger version (27K):
[in this window]
[in a new window]
|
Figure 3.
Effect of estrogen on and sex differences in
rotational behavioral induced by repeated treatment with 10 mg/kg
cocaine. Left, Mean ± SEM number of net rotations
per hour during each of the 12 test sessions. The OVX+E group
(n = 9; solid triangles) was treated
with 5 µg of EB 30 min before 10 mg/kg cocaine. Open
circles represent the data from OVX females
(n = 8), open diamonds the data from
CAST male rats (n = 8), and solid
squares the data from SHAM male rats (n = 7). Right, Mean ± SEM rate of sensitization from
linear regression calculated for each rat from the data for the first
eight testing sessions. **Net rotations per hour for OVX+E animals were
significantly greater than for OVX (p < 0.0001), CAST (p < 0.0001), and SHAM
(p < 0.0001) groups; ***rate of
sensitization for OVX+E animals was significantly greater than for OVX
(p < 0.038), CAST
(p < 0.022), and SHAM
(p < 0.014) groups.
|
|
On a two-way ANOVA test, there was a significant interaction between
group and session in the number of net rotations
(F(3,11) = 1.572, p < 0.028; group
F(3,27) = 11.684, p < 0.0001; session, F(11,33) = 18.486, p < 0.0001). In post hoc comparisons, the
OVX+E group receiving 10 mg/kg cocaine exhibited more net rotations than did all other groups when the entire 12 sessions of behavior were
compared (p < 0.0001). There was no significant
difference between the OVX, CAST, and SHAM groups.
Cocaine at 5 mg/kg
As illustrated in Figure 4, estrogen
also enhanced the rate of sensitization and net rotations induced by
repeated treatment with 5 mg/kg cocaine. All of the groups showed an
increase in rotational behavior over the 12 testing sessions, but the
OVX+E female groups exhibited greater net rotations during the 12 testing sessions than did all other groups. On a one-way ANOVA test,
there were group differences in the rate of sensitization in rotations (F(3,34) = 3.871; p < 0.0175). On post hoc comparisons, the rate of sensitization
of the OVX+E group was greater than that of the CAST
(p < 0.0041) and SHAM (p < 0.0109) groups. There was no significant difference between the
OVX+E and OVX groups, between the OVX and CAST groups, and between the
two male groups.

View larger version (23K):
[in this window]
[in a new window]
|
Figure 4.
Effect of estrogen on and sex differences in
rotational behavior induced by repeated treatment with 5 mg/kg cocaine.
Left, Mean ± SEM number of net rotations per hour
during each of the 12 test sessions. The OVX+E group
(n = 11; solid triangles) was
treated with 5 µg of EB 30 min before 5 mg/kg cocaine. Open
circles represent the data from OVX females
(n = 8), open diamonds the data from
CAST male rats (n = 10), and solid
squares the data from SHAM male rats (n = 9). Right, Mean ± SEM rate of sensitization from
linear regression calculated for each rat from the data for the first
eight testing sessions. **Net rotations per hour for OVX+E animals were
significantly greater than for OVX (p < 0.0001), CAST (p < 0.0001), and SHAM
(p < 0.0001) groups; ***rate of
sensitization for OVX+E animals was significantly greater than for CAST
(p < 0.004) and SHAM
(p < 0.01) groups.
|
|
On a two-way ANOVA, there was a significant interaction between group
and session (F(33,308) = 2.088, p < 0.0007; effect of group,
F(3,28) = 8.953, p < 0.0003; effect of session, F(11,28) = 10.635, p < 0.0001). In post hoc
comparisons, the OVX+E group receiving 5 mg/kg cocaine exhibited
greater rotational behavior than did all other groups when the entire
12 sessions of behavior were compared (p < 0.0001). There were no significant differences between the OVX, CAST,
and SHAM groups.
Saline
There was no effect of repeated saline treatment on rotational
behavior (Fig. 5). None of the groups
showed increased rotational behavior over the 12 testing sessions. A
one-way ANOVA test of the slopes of all groups indicated that there was
no effect of group (F(3,25) = 0.038;
p = 0.99). When net rotations were compared on a
two-way ANOVA, there was no significant interaction between groups and
sessions (F(33,275) = 0.869;
p = 0.677).

View larger version (16K):
[in this window]
[in a new window]
|
Figure 5.
No effect of estrogen or sex on rotational
behavioral induced by saline. Left, Mean ± SEM
number of net rotations per hour on each of the 12 test sessions. The
OVX+E group (n = 7; solid triangles)
were treated with 5 µg of EB 30 min before saline. Open
circles represent the data from OVX females
(n = 8), open diamonds the data from
CAST male rats (n = 7), and solid
squares the data from SHAM male rats (n = 7). Right, Mean ± SEM rate of change in rotations
calculated from linear regressions calculated for each rat from the
data for 12 testing sessions.
|
|
Dose-response
All groups exhibited differences in the magnitude or rate of
sensitization depending on dose of cocaine (compare Figs. 2-5). For
the OVX+E group, there was a significant effect of dose on the rate of
sensitization (F(3,31) = 15.886;
p < 0.0001). On post hoc comparisons, the
rate of sensitization of the OVX+E rats treated with 20 mg/kg cocaine
was greater (p < 0.001) than for the 10 mg/kg
group, the 5 mg/kg group, and the saline group. The rate of
sensitization of the OVX+E rats treated with 10 mg/kg cocaine was
greater than that of the saline group (p < 0.015) but not the 5 mg/kg group. There was also a significant effect
of dose on the magnitude of sensitization
(F(3,594) = 281.23; p < 0.0001). On post hoc comparisons, all dose groups were
significantly different from each other (p < 0.0001).
There was a significant effect of dose on the rate of sensitization for
the OVX group (F(3,28) = 18.427;
p < 0.0001). On post hoc comparisons, the
rate of sensitization of the OVX rats treated with 20 mg/kg cocaine was
greater (p < 0.001) than the other doses of
cocaine. The rate of sensitization of the OVX rats treated with 10 mg/kg cocaine was greater than that of the saline group (p < 0.025) but not the 5 mg/kg group. There
was also a significant effect of dose on the magnitude of sensitization
(F(3,380) = 132.847; p < 0.0001). On post hoc comparisons, for the 5 mg/kg versus
the saline group, the confidence level was p = 0.0174;
for the rest of the comparisons across doses, the confidence level was
at p < 0.0001.
For the CAST group, there was a significant effect of dose on the rate
of sensitization (F(3,29) = 9.649;
p < 0.0001). On post hoc comparisons, the
rate of sensitization of the CAST rats treated with 20 mg/kg cocaine
was greater than that of the 10 mg/kg group (p < 0.0345), the 5 mg/kg group (p < 0.0001), and the saline group (p < 0.0001). The rate of
sensitization of the CAST rats treated with 10 mg/kg cocaine was
greater than that of the 5 mg/kg group (p < 0.0295) and saline group (p < 0.0232). There was also a significant effect of dose on the magnitude of sensitization (F(3,390) = 121.791;
p < 0.0001). On post hoc comparisons, the
responses at all doses were significantly different
(p < 0.0001), except for the 5 mg/kg versus
saline groups, which did not differ (p = 0.1379).
For the SHAM group, there was a significant effect of dose on the rate
of sensitization (F(3,26) = 4.351;
p < 0.013). On post hoc comparisons, the
rate of sensitization of the SHAM rats treated with 20 mg/kg cocaine
was greater than that of the 5 mg/kg group (p < 0.0089) and saline group (p < 0.0033) but not
the 10 mg/kg group. There was also a significant effect of dose on the
magnitude of sensitization (F(3,354) = 112.58; p < 0.0001). On post hoc comparisons, the power of the significance level for 5 mg/kg versus saline was p = 0.0038; for the rest of the comparisons
across doses, the confidence level was at p < 0.0001.
Challenge day
On the challenge day (10 d after the last day of the original test
schedule), all rats received 10 mg/kg cocaine, but no groups were
treated with estrogen. The OVX+E groups showed significantly more net
rotations than the other three groups, regardless of previous cocaine
history (Fig. 6). When net rotations were
compared, there was a significant effect of group
(F(3,9) = 13.771; p < 0.0001) and no interaction between previous dose and group
(F(3,59) = 1.815; p = 0.154). There was no significant difference between groups with
previous saline treatment (F(3,25) = 2.088; p = 0.127). When the response on the challenge
day for each cocaine-treated group was compared with the response of
the comparable saline-treated groups, all groups showed sensitization
after pretreatment with 10 or 20 mg/kg, but after pretreatment with 5 mg/kg, the mean responses to the 10 mg/kg challenge dose were not
different from the responses of the saline-pretreated animals, except
for the OVX+E group (p = 0.023) (Fig. 6).

View larger version (24K):
[in this window]
[in a new window]
|
Figure 6.
Challenge day: mean ± SEM number of net
rotations per hour. On the challenge day (10 d after the last day of
the original test schedule), all rats received 10 mg/kg cocaine, but no
groups were treated with estrogen. Gray bars represent
the data from SHAM male rats, stippled bars the data
from CAST male rats, open bars the data from OVX female
rats, and solid bars the data from OVX+E female rats.
***Net rotations per hour for OVX+E animals were significantly greater
than for OVX (p < 0.0013), CAST
(p < 0.0004), and SHAM groups
(p < 0.0001).
|
|
 |
Discussion |
This is the first study to demonstrate sex differences in
behavioral sensitization in the absence of gonadal hormones and that
pulsatile estrogen treatment enhances sensitization of cocaine-induced rotational behavior in OVX female rats. At 20 mg/kg, OVX females exhibit a greater magnitude of sensitization than do CAST males. At all
doses of cocaine tested, OVX+E rats exhibited greater magnitude of
sensitization of rotational behavior to cocaine and a significantly greater rate of sensitization than did OVX rats and both male groups,
demonstrating that estrogen enhances the rate and magnitude of
sensitization of cocaine-induced rotational behavior.
In this study, we did not find sex differences or effects of estrogen
on the first acute response to cocaine. This finding is consistent with
reports of no sex differences in cocaine-stimulated motor behavior in
rats (Craft and Stratman, 1996 ; Cailhol and Mormede, 1999 ) and in mice
(Sershen et al., 1998 ). However, others have reported that intact
females exhibit greater stereotyped behaviors and locomotor activity
induced by acute cocaine than do males (van Haaren and Meyer, 1991 ;
Sell et al., 2000 ; Walker et al., 2001 ). The differences in the results
of these studies could be a result of the difference between the
acute estrogen exposure on the first day of the study reported here
versus more extensive estrogen treatment (i.e., silastic capsules
filled with estradiol) or intact females (that have been exposed to
estrogen for a few days). It is also possible that, on the first day of testing, the behavioral response is influenced by the animal's previous experience. For example, Walker et al. (2001) reported no
difference between intact and OVX in the acute response to 10 mg/kg
cocaine if animals underwent vaginal lavage, whereas OVX females that
were not handled in this way exhibited less activity. All of our
animals were handled extensively before the beginning of the experiment
and underwent vaginal lavage for 10 d.
Extensive literature documents that females have a greater acute
response to AMPH than males (Meyer, 1977 ; Savageau and Beatty, 1981 ;
Becker et al., 1982 , 1999 ; Camp et al., 1986 ; Camp and Robinson, 1988a ;
Becker and Cha, 1989 ). There is also estrous cycle-dependent variation
in behavior induced by AMPH (Becker et al., 1982 ; Becker and Cha,
1989 ), and estrogen rapidly enhances the behavioral and neurochemical
response to AMPH (Becker, 1990; Becker and Rudick, 1999 ). Differences
in the actions of AMPH versus cocaine may underlie the different
results found here for cocaine and the response to AMPH in other
studies. AMPH and cocaine both act at the DA transporter to prevent DA
reuptake, but AMPH has an added effect of inducing the release of DA
(Pifl and Singer, 1999 ; Sitte et al., 2001 ). This additional effect of
AMPH may exacerbate the acute response to the drug and produce
behavioral effects not seen with cocaine.
Although ovariectomy reduces the acute response to AMPH, both intact
and OVX female rats show AMPH-induced sensitization (Camp and Robinson,
1988b ). Because the two groups do not exhibit the same magnitude of
initial behavior response, it has been difficult to evaluate whether
there was an effect of ovarian hormones on sensitization to AMPH. One
must decide what is the best measure of sensitization: the absolute
change, the rate of change, or the percentage change in behavior. When
groups start out with a different initial response, one can get very
different answers, depending on the metric that is used to assess
sensitization. The failure to find an initial difference between groups
in the response to cocaine in the study presented here makes it
possible to directly compare both the magnitude and rate of
cocaine-induced behavioral sensitization across groups, and we find
that sex of the animal and estrogen treatment affect both.
Camp and Robinson (1988a) reported that female rats exhibit greater
AMPH-induced sensitization than do male rats, even when given a lower
dose of AMPH. Other studies have reported sex differences in
sensitization of AMPH-induced rotational behavior at a high dose of
AMPH but not at a low dose (Robinson, 1984 ). With cocaine, females
again are reported to exhibit greater behavioral sensitization than
males (van Haaren and Meyer, 1991 ). Female rats also demonstrate a
higher level of sensitization to repeated cocaine administration (Glick
and Hinds, 1984 ) and become sensitized with a lower dose of cocaine
than male rats (Post et al., 1981 ). These studies, however, did not
address whether the sex differences are a result of sex differences in
circulating gonadal hormones (i.e., activational effects) or
developmental sex differences (i.e., organizational effects), as we do
in the study reported here.
A few studies have addressed effects of estrogen on cocaine-induced
behavioral sensitization. Peris et al. (1991) showed that OVX female
rats treated with chronic estrogen display a significantly greater
degree of cocaine-induced behavioral sensitization. Chronic estrogen
also increased sensitivity of female rats to repeated cocaine treatment
(Sircar and Kim, 1999 ). Recently, Sell et al. (2002) reported that, in
OVX rats with chronic estrogen implants, there is an enhanced response
to repeated cocaine treatments, although in this study, estrogen alone
increased the first response to cocaine, so it is not clear that there
was enhanced sensitization (Sell et al., 2002 ). Extremely high doses of
estradiol or chronic treatment with physiological doses of estrogen
have been shown to induce downregulation of presynaptic DA activity (Di
Paolo et al., 1982 , 1983 ; Morissette and Di Paolo, 1993 ) and produce DA
receptor supersensitivity (Hruska and Silbergeld, 1980 ; Di Paolo et
al., 1981 , 1994 ; Hruska, 1986 ; Morissette et al., 1992 ). During the
estrous cycle, the female rat is exposed to an increase in estradiol
that occurs primarily during the morning of proestrus and falls rapidly
after that (McCarthy and Becker, 2002 ). We argue, therefore, that the
effect of chronic estrogen on cocaine-induced sensitization seen in
previous studies may not be mediated by the same mechanisms that make
intact female rats more responsive to cocaine sensitization than male
rats and that the pulsatile estrogen treatment schedule used here is
more appropriate for assessing physiological mechanisms.
Intriguingly, for male rats, CAST decreases AMPH-induced sensitization
without affecting the acute behavioral response to AMPH (Robinson,
1984 ; Forgie and Stewart, 1994 ). Attempts to enhance sensitization in
CAST males by replacing testosterone, however, have not been successful
(Forgie and Stewart, 1994 ), so the mechanism mediating the effect of
CAST on sensitization to AMPH remains to be determined. In this study,
we did not find a difference between SHAM and CAST rats in
sensitization to cocaine at any dose.
Intact male rats metabolize AMPH more rapidly than females, so less
AMPH reaches the brain (Becker et al., 1982 ). However, even when male
and female rats are given different doses of AMPH to produce equivalent
brain concentrations of the drug, females still exhibit a greater
behavioral response (Becker et al., 1982 ; Camp et al., 1986 ). Thus,
differences in drug metabolism cannot entirely explain the sex
difference in response to AMPH. In contrast to AMPH, plasma and brain
concentrations of cocaine are the same in male and female rats after
intraperitoneal injection (Bowman et al., 1999 ). Furthermore, the same
study showed that ovariectomy and castration did not affect plasma and
brain cocaine concentrations. Thus, the sex differences in response to
AMPH and cocaine may result from innate differences in their neural
targets, most likely the dopamine system.
Finally, the results of this study on the challenge day present
exciting new information about the persistence of the effect of
estrogen on sensitization. The use of a challenge dose after a 7-10 d
withdrawal period is a common way to determine the persistence of the
effect of the sensitization to the drug. Although we assume that
estradiol was no longer elevated at this time, we did not measure serum
values in these animals. Thus, the reader must be aware that it is
possible that we did not fully achieve zero estrogen on the
challenge day. Nevertheless, the enhancement of behavior seen in OVX+E
animals over OVX animals in the absence of additional estrogen
treatment is a phenomenon not tested or seen in previous studies. The
significance of the differences between the OVX+E and the OVX female
rats on the challenge day, in the absence of estrogen treatment,
suggests that there are long-term effects of cocaine exposure in the
presence of estrogen that differ from the effects of cocaine exposure
alone. The repercussions of the application of this model to human drug
addiction are intriguing; it indicates that sensitization accrued
during drug use under conditions of enhanced estrogen will persist even
when estrogen levels are low.
It has been reported that women are less likely to try cocaine,
but the likelihood that someone who has tried cocaine will develop
lifelong cocaine dependence is greater for women than for men (Kandel
et al., 1995 ; Wetherington and Roman, 1995 ). In addition, a recent
report by Justice and de Wit (1999) reports that higher levels of
estrogen are associated with greater amphetamine-induced euphoria,
energy, and intellectual efficiency. We interpret these results as
indicating that there are differences between men and women in the
neurobiological consequences of being exposed to the psychomotor
stimulants that result in women being at increased risk for addiction
to these drugs. Sensitization has been proposed as one of the possible
behavioral correlates of craving, and, because females exhibit greater
sensitization to cocaine than do males, we believe that this is a
viable animal model with which to begin to examine sex differences in
the neurobiological consequences of repeated cocaine administration.
The results of our study may lead to a better understanding of the
underlying neurobiological mechanisms mediating this sex difference.
The ultimate goal would be to target treatments to reduce this risk. At
the very least, understanding the cause of the greater risk of
addiction for women may contribute to better intervention and
prevention strategies.
 |
FOOTNOTES |
Received Aug. 21, 2002; revised Oct. 8, 2002; accepted Oct. 28, 2002.
This work was supported by United States Public Health Service Grant
DA12677 from the National Institute for Drug Abuse. We thank Dr. Terry
Robinson for fruitful discussions.
Correspondence should be addressed to Jill B. Becker, Psychology
Department, Biopsychology Area, 525 East University, Ann Arbor, MI
48109-1109. E-mail: jbbecker{at}umich.edu.
 |
References |
-
Becker JB
(1990a)
Direct effect of 17
-estradiol on striatum: sex differences in dopamine release.
Synapse
5:157-164[Web of Science][Medline]. -
Becker JB
(1990b)
Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis.
Neurosci Lett
118:169-171[Web of Science][Medline].
-
Becker JB
(1999)
Gender differences in and influences of reproductive hormones on dopaminergic function in striatum and nucleus accumbens.
Pharmacol Biochem Behav
64:803-812[Web of Science][Medline].
-
Becker JB
(2000)
Oestrogen effects on dopaminergic function in striatum.
In: Neuronal and cognitive effects of oestrogens (Chadwick DJ,
Goode JA,
eds), pp 134-151. Chichester, UK: Wiley.
-
Becker JB,
Cha J
(1989)
Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis.
Behav Brain Res
35:117-125[Web of Science][Medline].
-
Becker JB,
Freed WJ
(1988)
Neurochemical correlates of behavioral changes following intraventricular adrenal medulla grafts: intraventricular microdialysis in freely moving rats.
Prog Brain Res
78:527-533[Web of Science][Medline].
-
Becker JB,
Ramirez VD
(1981)
Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro.
Brain Res
204:361-372[Web of Science][Medline].
-
Becker JB,
Rudick CN
(1999)
Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study.
Pharmacol Biochem Behav
64:53-57[Web of Science][Medline].
-
Becker JB,
Robinson TE,
Lorenz KA
(1982)
Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior.
Eur J Pharmacol
80:65-72[Web of Science][Medline].
-
Berridge KC,
Robinson TE
(1995)
The mind of an addicted brain: neural sensitization of wanting versus liking.
Curr Direct Psychol Sci
4:71-76.
-
Bowman BP,
Vaughan SR,
Walker QD,
Davis SL,
Little PJ,
Scheffler NM,
Thomas BF,
Kuhn CM
(1999)
Effects of sex and gonadectomy on cocaine metabolism in the rat.
J Pharmacol Exp Ther
290:1316-1323[Abstract/Free Full Text].
-
Butcher RL,
Collins WE,
Fugo NW
(1974)
Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat.
Endocrinology
94:1704-1708[Abstract/Free Full Text].
-
Cailhol S,
Mormede P
(1999)
Strain and sex differences in the locomotor response and behavioral sensitization to cocaine in hyperactive rats.
Brain Res
842:200-205[Web of Science][Medline].
-
Camp DM,
Robinson TE
(1988a)
Susceptibility to sensitization. I. Sex differences in the enduring effects of chronic D-amphetamine treatment on locomotion, stereotyped behavior and brain monoamines.
Behav Brain Res
30:55-68[Web of Science][Medline].
-
Camp DM,
Robinson TE
(1988b)
Susceptibility to sensitization. II. The influence of gonadal hormones on enduring changes in brain monoamines and behavior produced by the repeated administration of D-amphetamine or restraint stress.
Behav Brain Res
30:69-88[Web of Science][Medline].
-
Camp DM,
Becker JB,
Robinson TE
(1986)
Sex differences in the effects of gonadectomy on amphetamine-induced rotational behavior in rats.
Behav Neural Biol
46:491-495[Web of Science][Medline].
-
Castner SA,
Xiao L,
Becker JB
(1993)
Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies.
Brain Res
610:127-134[Web of Science][Medline].
-
Cheng HC,
Johnson DC
(1974)
Temporal changes in serum estradiol and prolactin in immature female rats given a single injection of estradiol benzoate.
Steroids
24:657-664[Web of Science][Medline].
-
Craft RM,
Stratman JA
(1996)
Discriminative stimulus effects of cocaine in female versus male rats.
Drug Alcohol Depend
42:27-37[Web of Science][Medline].
-
Di Paolo T
(1994)
Modulation of brain dopamine transmission by sex steroids.
Rev Neurosci
5:27-41[Medline].
-
Di Paolo T,
Poyet P,
Labrie F
(1981)
Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors.
Eur J Pharmacol
73:105-106[Web of Science][Medline].
-
Di Paolo T,
Dupont A,
Daigle M
(1982)
Effect of chronic estradiol treatment on dopamine concentrations in discrete brain nuclei of hypophysectomized female rats.
Neurosci Lett
32:295-300[Web of Science][Medline].
-
Di Paolo T,
Diagle M,
Picard V,
Barden N
(1983)
Effect of acute and chronic 17 beta-estradiol treatment on serotonin and 5-hydroxyindole acetic acid content of discrete brain nuclei of ovariectomized rat.
Exp Brain Res
51:73-76[Web of Science][Medline].
-
Forgie ML,
Stewart J
(1994)
Sex difference in amphetamine-induced locomotor activity in adult rats: role of testosterone exposure in the neonatal period.
Pharmacol Biochem Behav
46:637-645.
-
Glick SD,
Hinds PA
(1984)
Sex differences in sensitization to cocaine-induced rotation.
Eur J Pharmacol
99:119-121[Web of Science][Medline].
-
Griffin ML,
Weiss RD,
Lange U
(1989)
A comparison of male and female cocaine abuse.
Arch Gen Psychiatry
46:122-126[Abstract/Free Full Text].
-
Henderson SR,
Baker C,
Fink G
(1977a)
Oestradiol-17
and pituitary responsiveness to luteinizing hormone releasing factor in the rat: a study using rectangular pulses of estradiol-17 monitored by non-chromatographic radioimmunoassay.
J Endocrinol
73:441-453[Abstract/Free Full Text]. -
Henderson SR,
Baker C,
Fink G
(1977b)
Effect of oestradiol-17beta exposure on the spontaneous secretion of gonadotrophins in chronically gonadectomized rats.
J Endocrinol
73:455-462[Abstract/Free Full Text].
-
Hruska RE
(1986)
Elevation of striatal dopamine receptors by estrogen: dose and time studies.
J Neurochem
47:1908-1915[Web of Science][Medline].
-
Hruska RE,
Silbergeld EK
(1980)
Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum.
Eur J Pharmacol
61:397-400[Web of Science][Medline].
-
Justice AJH,
de Wit H
(1999)
Acute effects of D-amphetamine during the follicular and luteal phases of the menstrual cycle in women.
Psychopharmacology (Berl)
145:67-75[Medline].
-
Kandel DB,
Warner MPP,
Kessler RC
(1995)
The epidemiology of substance abuse and dependence among women.
In: Drug addiction research and the health of women. Rockville, MD: United States Department of Health and Human Resources.
-
Kosten TA,
Gawin FH,
Kosten TR,
Rounsaville BJ
(1993)
Gender differences in cocaine use and treatment response.
J Subst Abuse Treat
10:63-66[Web of Science][Medline].
-
Lett BT
(1989)
Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine.
Psychopharmacology (Berl)
98:357-362[Medline].
-
Lynch WJ,
Carroll ME
(1999)
Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats.
Psychopharmacology (Berl)
144:77-82[Medline].
-
Mallampati RS,
Johnson DC
(1973)
Serum and pituitary luteinizing hormone, follicle stimulating hormone, and prolactin in gonadectomized male, female and androgenized female rats treated with oestradiol benzoate.
J Endocrinol
59:209-216[Abstract/Free Full Text].
-
McCarthy MM,
Becker JB
(2002)
Neuroendocrinology of sexual behavior in the female.
In: Behavioral endocrinology (Becker JB,
Breedlove SM,
Crews D,
McCarthy MM,
eds), pp 117-151. Cambridge, MA: MIT/Bradford.
-
McFarlane DK,
Martonyi BJ,
Robinson TE
(1992)
An inexpensive automated system for the measurement of rotational behavior in small animals.
Behav Res Methods Instrum Comput
24:414-419[Web of Science].
-
Mendelson JH,
Weiss R,
Griffin M,
Mirin SM,
Teoh SK,
Mello NK,
Lex BW
(1991)
Some special considerations for treatment of drug abuse and dependence in women.
NIDA Res Monogr
106:313-327[Medline].
-
Meyer Jr E
(1977)
Age-and sex-related differences in amphetamine-induced locomotor activity.
Fed Proc
36:1033.
-
Morissette M,
Di Paolo T
(1993)
Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites.
J Neurochem
60:1876-1883[Web of Science][Medline].
-
Morissette M,
Levesque D,
Di Paolo T
(1992)
Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
Mol Pharmacol
42:480-488[Abstract].
-
Peris J,
Decambre N,
Coleman-Hardee M,
Simpkins J
(1991)
Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated [3H]dopamine release.
Brain Res
566:255-264[Web of Science][Medline].
-
Piazza PV,
Deminière JM,
Le Moal M,
Simon H
(1990)
Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration.
Brain Res
514:22-26[Web of Science][Medline].
-
Pifl C,
Singer EA
(1999)
Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion.
Mol Pharmacol
56:1047-1054[Abstract/Free Full Text].
-
Post RM,
Lockfeld A,
Squillace KM,
Contel NR
(1981)
Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization.
Life Sci
28:755-760[Web of Science][Medline].
-
Robbins SJ,
Ehrman RN,
Childress AR,
O'Brien CP
(1999)
Comparing levels of cocaine cue reactivity in male and female outpatients.
Drug Alcohol Depend
53:223-230[Web of Science][Medline].
-
Robinson TE
(1984)
Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats.
Psychopharmacology (Berl)
84:466-475[Medline].
-
Robinson TE,
Becker JB
(1986)
Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.
Brain Res Rev
396:157-198.
-
Robinson TE,
Berridge KC
(1993)
The neural basis of drug craving: an incentrive-sensitization theory of addiction.
Brain Res Rev
18:247-291[Medline].
-
Robinson TE,
Becker JB,
Presty SK
(1982)
Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences.
Brain Res
253:231-241[Web of Science][Medline].
-
Savageau MM,
Beatty WW
(1981)
Gonadectomy and sex differences in the behavioral responses of amphetamine and apomorphine of rats.
Pharmacol Biochem Behav
14:17-23[Web of Science][Medline].
-
Sell SL,
Scalzitti JM,
Thomas ML,
Cunningham KA
(2000)
Influence of ovarian hormones and estrous cycle on the behavioral response to cocaine in female rats.
J Pharmacol Exp Ther
293:879-886[Abstract/Free Full Text].
-
Sell SL,
Thomas ML,
Cunningham KA
(2002)
Influence of estrous cycle and estradiol on behavioral sensitization to cocaine in female rats.
Drug Alcohol Depend
67:281-290[Web of Science][Medline].
-
Sershen H,
Hashim A,
Lajtha A
(1998)
Gender differences in kappa-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release.
Brain Res
801:67-71[Web of Science][Medline].
-
Sircar R,
Kim D
(1999)
Female gonadal hormones differentially modulate cocaine-induced behavioral sensitization in Fischer, Lewis, and Sprague-Dawley rats.
J Pharmacol Exp Ther
289:54-65[Abstract/Free Full Text].
-
Sitte HH,
Hiptmair B,
Zwach J,
Pifl C,
Singer EA,
Scholze P
(2001)
Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion.
Mol Pharmacol
59:1129-1137[Abstract/Free Full Text].
-
Strakowski SM,
Sax KW,
Setters MJ,
Keck Jr PE
(1996)
Enhanced response to repeated D-amphetamine challenge: evidence for behavioral sensitization in humans.
Biol Psychiatry
40:872-880[Web of Science][Medline].
-
van Haaren F,
Meyer M
(1991)
Sex differences in the locomotor activity after acute and chronic cocaine administration.
Pharmacol Biochem Behav
39:923-927[Web of Science][Medline].
-
Walker QD,
Cabassa J,
Kaplan KA,
Li ST,
Haroon J,
Spohr HA,
Kuhn CM
(2001)
Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy.
Neuropsychopharmacology
25:118-130[Web of Science][Medline].
-
Wetherington CL,
Roman AR
(1995)
In: Drug addiction research and the health of women, pp 105-130. Rockville, MD: United States Department of Health and Human Services.
-
Wyvell CL,
Berridge KC
(2001)
Incentrive sensitization by previous amphetamine exposure: increased cue-triggered "wanting" for sucrose reward.
J Neurosci
21:7831-7840[Abstract/Free Full Text].
Copyright © 2003 Society for Neuroscience 0270-6474/03/232693-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
K. N. Schultz, S. A. von Esenwein, M. Hu, A. L. Bennett, R. T. Kennedy, S. Musatov, C. D. Toran-Allerand, M. G. Kaplitt, L. J. Young, and J. B. Becker
Viral Vector-Mediated Overexpression of Estrogen Receptor-{alpha} in Striatum Enhances the Estradiol-Induced Motor Activity in Female Rats and Estradiol-Modulated GABA Release
J. Neurosci.,
February 11, 2009;
29(6):
1897 - 1903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Febo, C. F. Ferris, and A. C. Segarra
Estrogen Influences Cocaine-Induced Blood Oxygen Level-Dependent Signal Changes in Female Rats
J. Neurosci.,
February 2, 2005;
25(5):
1132 - 1136.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|